News
Charles River generated best-in-class data with Kytopen’s Flowfect™ technology in comparative...
September 17, 2024
Kytopen awarded competitive phase II SBIR fast-track funding for “Non-Activated Natural Killer...
August 13, 2024
Kytopen announces the first implementation of its GMP compliant Flowfect Tx™ cellular engineering...
July 16, 2024
Kytopen announces appointment of industry executive Kevin Gutshall as Chief Commercial Officer ...
April 09, 2024
Kytopen Announces Launch of Technology Access Program Supported by an Expanded Applications Team
March 26, 2024
Read the original release at PR Newswire
September 21, 2023
Company Adds Proven Product Development and Commercial Leader as it Accelerates Launch of Flowfect®...
August 07, 2023
CAMBRIDGE, Mass. — July 11, 2023 — Kytopen, a leading biotechnology company specializing in...
July 11, 2023
On International Women in Engineering Day, we pay tribute to the exceptional women who have...
June 23, 2023
Today, we celebrate Kytopen's sixth anniversary, a journey filled with groundbreaking achievements...
June 12, 2023